The importance of resuming hormone treatment after pregnancy. Case presentation: invasive ductal carcinoma RH+, HER2/Neu+

, Dominic Iliescu, , ,

Introducere. În prezent, incidenţa cancerului de sân la gravide este în creştere, iar unul dintre motive ar putea fi vârsta crescută la prima sarcină....

Second primary breast cancer during PARP inhibitor treatment of somatic BRCA mutant ovarian cancer – a case report

, ,

Ovarian cancer is the fifth cause of death by cancer in the female population from Romania(1). Mutations in the BRCA1 (breast cancer gene 1) and BRCA2 (breast cancer gene 2) lead to an increased risk ...